Another application where iPSC-derived lung models show great promise is in modelling genetic diseases, including cystic fibrosis, primary ciliary dyskinesia, alpha-1 antitrypsin deficiency, and interstitial lung disease. This evidence concerns the gene SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4.